Alignment Healthcare (NASDAQ:ALHC) Insider Hyong Kim Sells 33,655 Shares of Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Hyong Kim sold 33,655 shares of the company’s stock in a transaction dated Wednesday, October 8th. The shares were sold at an average price of $17.29, for a total transaction of $581,894.95. Following the completion of the sale, the insider directly owned 413,712 shares of the company’s stock, valued at $7,153,080.48. The trade was a 7.52% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Hyong Kim also recently made the following trade(s):

• On Thursday, October 9th, Hyong Kim sold 51,379 shares of Alignment Healthcare stock. The shares were sold at an average price of $17.57, for a total transaction of $902,729.03.
• On Friday, August 22nd, Hyong Kim sold 24,800 shares of Alignment Healthcare stock. The stock was sold at an average price of $16.00, for a total transaction of $396,800.00.
• On Monday, August 11th, Hyong Kim sold 18,600 shares of Alignment Healthcare stock. The stock was sold at an average price of $14.54, for a total transaction of $270,444.00.

Alignment Healthcare Trading Down 1.4%

NASDAQ ALHC opened at $17.31 on Friday. The stock has a market capitalization of $3.43 billion, a P/E ratio of -61.82 and a beta of 1.18. Alignment Healthcare, Inc. has a 52-week low of $10.11 and a 52-week high of $21.06. The firm has a 50-day moving average price of $16.06 and a 200 day moving average price of $15.67. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 2.29.

Alignment Healthcare (NASDAQ:ALHC) last posted its quarterly earnings results on Wednesday, July 30th. The company reported $0.07 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.07) by $0.14. The firm had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $960.25 million. Alignment Healthcare had a negative net margin of 1.53% and a negative return on equity of 43.68%. The firm’s revenue for the quarter was up 49.0% on a year-over-year basis. During the same period in the prior year, the company posted ($0.13) earnings per share. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Equities research analysts expect that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the business. Vanguard Group Inc. increased its stake in shares of Alignment Healthcare by 13.2% during the 1st quarter. Vanguard Group Inc. now owns 11,113,896 shares of the company’s stock worth $206,941,000 after purchasing an additional 1,295,825 shares in the last quarter. T. Rowe Price Investment Management Inc. increased its stake in shares of Alignment Healthcare by 5.0% during the 1st quarter. T. Rowe Price Investment Management Inc. now owns 9,078,113 shares of the company’s stock worth $169,035,000 after purchasing an additional 429,071 shares in the last quarter. Wellington Management Group LLP increased its stake in shares of Alignment Healthcare by 0.9% during the 1st quarter. Wellington Management Group LLP now owns 7,509,057 shares of the company’s stock worth $139,819,000 after purchasing an additional 70,557 shares in the last quarter. Hood River Capital Management LLC increased its stake in shares of Alignment Healthcare by 6.0% during the 2nd quarter. Hood River Capital Management LLC now owns 5,517,336 shares of the company’s stock worth $77,243,000 after purchasing an additional 311,424 shares in the last quarter. Finally, 8 Knots Management LLC increased its stake in shares of Alignment Healthcare by 6.4% during the 2nd quarter. 8 Knots Management LLC now owns 5,015,881 shares of the company’s stock worth $70,222,000 after purchasing an additional 300,409 shares in the last quarter. 86.19% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

ALHC has been the subject of several analyst reports. KeyCorp raised shares of Alignment Healthcare from a “sector weight” rating to an “overweight” rating and set a $21.00 price target for the company in a report on Monday, August 25th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Alignment Healthcare in a report on Wednesday. Zacks Research raised shares of Alignment Healthcare from a “hold” rating to a “strong-buy” rating in a report on Monday, September 29th. Barclays raised shares of Alignment Healthcare from an “underweight” rating to an “equal weight” rating and increased their target price for the company from $9.00 to $13.00 in a report on Thursday, July 31st. Finally, Wall Street Zen cut shares of Alignment Healthcare from a “buy” rating to a “hold” rating in a report on Sunday, August 10th. Two investment analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Alignment Healthcare has an average rating of “Moderate Buy” and a consensus price target of $18.83.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.